# TREM-1 Pathway Activation in COVID-19

> **NCT04544891** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 830 (actual)

## Conditions studied

- Covid19

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT04544891
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 830 (ACTUAL)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04544891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04544891, "TREM-1 Pathway Activation in COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04544891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*